Literature DB >> 15511502

Video-assisted thoracic surgery upper lobe trisegmentectomy for early-stage left apical lung cancer.

Ward V Houck1, Clark B Fuller, Robert J McKenna.   

Abstract

Resection of the left upper lobe with preservation of the lingula is the anatomic equivalent of a right upper lobectomy with preservation of the right middle lobe. Therefore, our standard operation for a small apical tumor in the left upper lobe has been an apical trisegmentectomy. The purpose of this article is to review our experience with the procedure by video-assisted thoracic surgery (VATS) and to describe the operative technique for a VATS apical trisegmentectomy. Eleven patients underwent the procedure with no deaths, low morbidity, and good initial disease-free survival. A VATS apical trisegmentectomy seems to be a feasible and reasonable treatment for small stage I lung cancers at the apex of the left upper lobe.

Entities:  

Mesh:

Year:  2004        PMID: 15511502     DOI: 10.1016/j.athoracsur.2003.09.139

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Techniques to define segmental anatomy during segmentectomy.

Authors:  Hiroyuki Oizumi; Hirohisa Kato; Makoto Endoh; Takashi Inoue; Hikaru Watarai; Mitsuaki Sadahiro
Journal:  Ann Cardiothorac Surg       Date:  2014-03

2.  Anatomical video-assisted thoracoscopic surgery segmentectomies based on the three-dimensional reformation images.

Authors:  Qianli Ma; Tong Bao; Haitao Zhang; Chaoyang Liang; Deruo Liu
Journal:  J Vis Surg       Date:  2017-02-20

Review 3.  Anatomical thoracoscopic segmentectomy for lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-03

4.  A new LigaSure technique for the formation of segmental plane by intravenous indocyanine green fluorescence during thoracoscopic anatomical segmentectomy.

Authors:  Hiroaki Kuroda; Hitoshi Dejima; Tetsuya Mizumo; Noriaki Sakakura; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.